In addition to advising the Department of Human Services, the Drug Use Review Board shall do the following subject to the approval of the Director of Human Services:
(1) Publish an annual report, as described in ORS 414.415.
(2) Publish and disseminate educational information to prescribers and pharmacists regarding the board and the drug use review programs, including information on the following:
(a) Identifying and reducing the frequency of patterns of fraud, abuse or inappropriate or medically unnecessary care among prescribers, pharmacists and recipients.
(b) Potential or actual severe or adverse reactions to drugs.
(c) Therapeutic appropriateness.
(d) Overutilization or underutilization.
(e) Appropriate use of generic products.
(f) Therapeutic duplication.
(g) Drug-disease contraindications.
(h) Drug-drug interactions.
(i) Drug allergy interactions.
(j) Clinical abuse and misuse.
(3) Adopt and implement procedures designed to insure the confidentiality of any information collected, stored, retrieved, assessed or analyzed by the board, staff of the board or contractors to the drug use review programs that identifies individual prescribers, pharmacists or recipients. [1993 c.578 §7]
Note: See note under 414.350.
Section: Previous 414.342 414.344 414.346 414.348 414.350 414.355 414.360 414.365 414.370 414.375 414.380 414.385 414.390 414.395 414.400 NextLast modified: August 7, 2008